ALEXANDRIA, Va., July 30 -- United States Patent no. 12,370,252, issued on July 29, was assigned to Emory University (Atlanta), Children's Healthcare of Atlanta (Atlanta) and Wisconsin Alumni Research Foundation (Madison, Wis.).

"RSV virus-like particles and methods of use thereof" was invented by Binh Ha (Atlanta), Larry J. Anderson (Atlanta) and Elizabeth R. Wright (Atlanta).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to virus-like particles and vaccine compositions for inducing immunity and preventing respiratory syncytial virus (RSV) infection. Specifically, the disclosure provides virus like-particles (VLPs) for use in inducing immunity to respiratory syncytial virus (RS...